Jazz-Roche lung cancer combo approved by FDA
The U.S. FDA has approved the priority sNDA for a new first-line maintenance therapy in extensive-stage small-cell lung…
Roche’s Tecentriq Cuts Death Risk 41% in ctDNA‑guided MIBC
Roche (OTCQX: RHHBY) reported positive phase III IMvigor011 results for Tecentriq (atezolizumab) as…